NPK Vitrotest Ltd was founded in 2006 and was established in Ukraine to start the production of enzyme immunoassays.
Vitrotest Sp. z o.o. with its seat in Gdańsk was established in 2014 and serves as the official representative for the Ukrainian company within the European Union.
Vitrotest Bioreagent LLC company was established as a result of the reorganization of NPK Vitrotest Ltd. with the acquisition of new investments. It produces ELISA test-kits for the diagnostics of infectious human diseases, and in March 2020 began producing test-kits for the diagnostics of COVID-19.
Vitrotest Europe Sp. z o.o.
In 2020, a team of scientists together with partners from the "Kvarko" fund established the first company in Poland, Vitrotest Europe Sp. z o.o., to promote the production of ELISA kits. In the same year, the company received a grant from the European Union and the National Center for Research and Development for the implementation of a project entitled "Development of new type of synthetic controls in ELISA diagnostic tests on the example of a measles virus infection detection test". Thanks to the grant, we will start the production of immunoenzymatic kits in Poland.
In addition, the company represents the Ukrainian producer of immunoenzymatic kits Vitrotest Bioreagent LLC in the European Union.